(Figure 8) The combined status of Cx43 and Bcl-2 did not correlate with DSS (p > 0.05), tumor localization (p = 0.904), tumor size (p = 0.687), stage (p = 0.924), lymph node metastasis (p = 0.43) or response to neoadjuvant chemotherapy (p > 0.05). The gene discussed is BCL2; the disease is neoplasm.